Abstract
Intrathecal methotrexate is the mainstay of central nervous system prophylaxis in acute lymphoblastic leukemia. We describe a patient who developed acute chorea after last dose of intrathecal methotrexate therapy and recovered completely.
MeSH terms
-
Acute Disease
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / adverse effects*
-
Child
-
Chorea / chemically induced*
-
Chorea / drug therapy
-
Female
-
Humans
-
Injections, Spinal
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Treatment Outcome
Substances
-
Antimetabolites, Antineoplastic
-
Methotrexate